7 completed, 6 recruiting, 4 unknown, 2 terminated. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 7, Recruiting 6, Unknown 4, Terminated 2, Active not recruiting 1, Withdrawn 1 |
Follow MRI: new trials by email Literature Review of MRI trials Research Report on MRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome Biological tests, MRI, Neuropsychological tests - Immune Effector Cell Associated Neurotoxicity Syndrome | Phase 4 | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 60 | 2025-07-02 | 2026-09-30 |
| Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging - Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | Phase 4 | Recruiting | Roswell Park Cancer Institute | 600 | 2025-01-15 | 2026-05-14 |
| Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide Insulin resistance testing, OGTT, Fat biopsy - Diabetes Mellitus, Type 2, Diabetes | Phase 4 | Recruiting | Stanford University | 104 | 2025-01-13 | 2026-04-20 |
| Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial Biospecimen Collection, Computed Tomography, Cystectomy - Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma | Phase 4 | Recruiting | Mayo Clinic | 75 | 2025-01-08 | 2026-10-01 |
| An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis Copper Cu 64-DOTA-Trastuzumab, Magnetic Resonance Imaging, Positron Emission Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 4 | Recruiting | City of Hope Medical Center | 10 | 2022-12-21 | 2026-07-01 |
| Investigational MRI Clinical Software and Hardware MRI, Gadavist 2Ml Solution for Injection - Image, Body | Phase 4 | Active not recruiting | Northwestern University | 2000 | 2019-12-19 | 2026-09-15 |
| Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase. MRI, MRI control, telephone consultation - Migraine Aura | Phase 4 | Completed | University Hospital, Toulouse | 60 | 2018-12-22 | 2021-02-03 |
| Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors Contrast Agent, Magnetic Resonance Imaging, Quality-of-Life Assessment - Malignant Oral Cavity Neoplasm, Malignant Skull Base Neoplasm | Phase 4 | Recruiting | M.D. Anderson Cancer Center | 425 | 2018-09-17 | 2026-05-22 |
| Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases Fludeoxyglucose F-18, Magnetic Resonance Imaging, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Phase 4 | Completed | M.D. Anderson Cancer Center | 12 | 2018-08-03 | 2024-05-01 |
| Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1 Nivolumab, MRI, BLOOD SAMPLES - Melanoma, Non-small Cell | Phase 4 | Unknown | Assistance Publique Hopitaux De Marseille | 50 | 2018-04-09 | 2023-04-21 |
| Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI Ferumoxytol-enhanced magnetic resonance imaging, Magentic Resonance Imaging - Osteonecrosis | Phase 4 | Completed | Stanford University | 14 | 2015-05-01 | 2024-11-26 |
| Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer Gadofosveset trisodium (Ablavar™ ), MRI - Ovarian Neoplasms | Phase 4 | Withdrawn | Maastricht University Medical Center | 2014-09-01 | 2015-09-28 | |
| ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study ShuntCheck-Micro-Pumper (SCMP), Imaging - Suspected CSF Shunt Obstruction | Phase 4 | Unknown | NeuroDx Development | 400 | 2013-05-01 | 2015-06-23 |
| Emotional and Cognitive Control in Late-Onset Depression Escitalopram, Magnetic Resonance Imaging - Depression | Phase 4 | Completed | Weill Medical College of Cornell University | 121 | 2012-07-01 | 2020-10-06 |
| Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer MRI - Invasive Breast Cancer | Phase 4 | Unknown | Mahidol University | 60 | 2011-02-01 | 2013-01-23 |
| The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis MRI, Radiography, Standard of Care - Inflammatory Arthritis | Phase 4 | Unknown | McMaster University | 186 | 2009-06-01 | 2011-10-07 |
| Magnetic Resonance Diabetic Cardiac Stress Imaging MRI, MPS - Coronary Insufficiency | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 62 | 2008-11-01 | 2012-07-31 |
| Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment MRI - Breast Neoplasm | Phase 4 | Completed | Karolinska University Hospital | 440 | 2008-02-01 | 2013-05-29 |
| Adult Growth Hormone Deficiency and Cardiovascular Risk Blood draws, growth hormone releasing hormone (GHRH) & arginine, Carotid ultrasound - Growth Hormone Deficiency | Phase 4 | Terminated | Columbia University | 7 | 2007-02-01 | 2022-11-16 |
| Canadian Pegvisomant Compassionate Study In Acromegalic Patients Pegvisomant treatment, Medical History, demographics, Sign and symptoms: questionnaire - Acromegaly | Phase 4 | Completed | Pfizer | 30 | 2004-11-01 | 2008-04-24 |
Showing 20 of 21. Sign in to see all of them.
Brain Neoplasms (2) · Breast Neoplasms (2) · Acromegaly (1) · Arthritis (1) · Atherosclerosis (1) · Behavioral Symptoms (1) · Coronary Disease (1) · Depression (1) · Depressive Disorder (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dwarfism, Pituitary (1) · Glucose Intolerance (1) · Hydrocephalus (1) · Insulin Resistance (1)
M.D. Anderson Cancer Center (2) · Stanford University (2) · Assistance Publique - Hôpitaux de Paris (1) · Assistance Publique Hopitaux De Marseille (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · City of Hope Medical Center (1) · Columbia University (1) · Guerbet (1) · Karolinska University Hospital (1) · Maastricht University Medical Center (1) · Mahidol University (1) · Mayo Clinic (1) · McMaster University (1) · NeuroDx Development (1) · Northwestern University (1)
United States (12) · France (4) · Canada (2) · Netherlands (1) · Sweden (1) · Thailand (1)
Ahmed Aly (1) · Alain Viguier, PH (1) · Brita Arver, MD PhD (1) · Colin E Webber, PhD CCPM (1) · David A Frim, MD (1) · David Chesler, MD (1) · David Sandberg, MD (1) · Dawid Schellingerhout (1) · Eddie Darton, MD (1) · Faith Gunning, Ph.D. (1) · George I Jallo, MD (1) · Heike Daldrup-Link, MD, PhD (1) · Jacob J. Orme, MD, PhD (1) · James Chamberlain, MD (1)
PMID 20003832, PMID 24997587, PMID 30224340, PMID 31077981, PMID 31901436, PMID 34611701, PMID 35230185, PMID 35895056
2017 (2), P30CA033572 (1), R01MH097735 (1), R44NS067772 (1)